Biomedicines (Sep 2022)

Identification of a Novel Missense Mutation of <i>POLR3A</i> Gene in a Cohort of Sicilian Patients with Leukodystrophy

  • Antonino Musumeci,
  • Francesco Calì,
  • Carmela Scuderi,
  • Mirella Vinci,
  • Girolamo Aurelio Vitello,
  • Sebastiano Antonino Musumeci,
  • Valeria Chiavetta,
  • Concetta Federico,
  • Greta Amore,
  • Salvatore Saccone,
  • Gabriella Di Rosa,
  • Antonio Gennaro Nicotera

DOI
https://doi.org/10.3390/biomedicines10092276
Journal volume & issue
Vol. 10, no. 9
p. 2276

Abstract

Read online

Recessive mutations in the POLR3A gene cause POLR3-HLD (the second-most-common form of childhood-onset hypomyelinating leukodystrophy), a neurodegenerative disorder featuring deficient cerebral myelin formation. To date, more than 140 POLR3A (NM_007055.3) missense mutations are related to the pathogenesis of POLR3-related leukodystrophy and spastic ataxia. Herein, in a cohort of five families from Sicily (Italy), we detected two cases of patients affected by POLR3-related leukodystrophy, one due to a compound heterozygous mutation in the POLR3A gene, including a previously undescribed missense mutation (c.328A > G (p.Lys110Glu)). Our study used an in-house NGS gene panel comprising 41 known leukodystrophy genes. Successively, we used a predictive test supporting the missense mutation as causative of disease, thus this mutation can be considered “Likely Pathogenic” and could be as a new pathogenetic mutation of the POLR3A gene causing a severe form of POLR3-HLD.

Keywords